Delivery Order SPE2DB20D3303-SPE2DB25FA1SN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,745.76 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.66 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% foam in a 10-gram formulation. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,515.44 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,637.16 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with a completion date of August 26, 2025, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award is...
- The Defense Logistics Agency awarded a $2,327.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.24 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries firm fixed pricing. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution center for federal...
- The Defense Logistics Agency awarded a $2,936.60 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in 10-gram units, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct procurement through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,572.00 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025. The award was made on September 25, 2025, and performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,902.53 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, with an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a global...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1SNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,051.70 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price procurement with no set-aside designation. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages its position as a prime contractor under the DLA's global pharmaceutical support framework to supply a broad range of medical products to military and veteran healthcare systems. This delivery order for a topical foam medication exemplifies the company's role in fulfilling specialized pharmaceutical procurement needs across the Defense Health Agency and other federal healthcare systems. The competitively awarded contract demonstrates AmerisourceBergen's capability to meet federal requirements across diverse product categories, from routine medications to specialized medical commodities supporting military readiness and healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/24/25 |